Defining Coordinated Care for People with Rare Conditions: A Scoping Review. by Walton, Holly et al.
Introduction
Living with a rare or common chronic condition can have 
a large impact on a person’s life, including their emo-
tional and psychological health and social and financial 
situation [1–4]. Accessing treatment for rare or common 
chronic conditions may be difficult if there are require-
ments to attend multiple health appointments, with 
different specialists, on different days or locations [5, 
Berenson, 2007; as cited in 6, 7, 8]. The impact of living 
with these conditions and experiences accessing treat-
ment are often exacerbated by disjointed care, for exam-
ple, needing to repeat information to different providers 
[5, 9]. To ease treatment burden and difficulties associ-
ated with disjointed care, and make it easier for people to 
access treatment, it has been argued that there are ben-
efits to coordinating care [5, 7, 10]. 
Collectively, rare conditions affect a significant propor-
tion of the population, both in the UK [7] and worldwide 
[11]. Rare conditions (including undiagnosed conditions) 
are often genetic disorders, can include both intellectual 
and physical health symptoms, and largely affect children 
[3, 12]. The European definition proposes that rare condi-
tions are conditions which have been diagnosed in fewer 
than five in 10,000 people in the general population [3, 
7]. Many, if not most, rare conditions are chronic, life-long 
conditions. ‘Chronic disease’ is an umbrella term used to 
refer to a range of long-term conditions (e.g. cardiovas-
cular disease, cancers, chronic respiratory diseases and 
diabetes) [13, 14]. Chronic conditions may include both 
common and rare conditions. 
In order to understand how care can be coordinated 
for patients with rare conditions, a clear definition of 
care coordination is needed in the context of rare con-
ditions. A definition could further our understanding of 
care coordination for rare diseases and could also help to 
identify situations where services are not coordinated, and 
as such may require improvement. A systematic review of 
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reviews conducted by McDonald et al. [15] defined care 
coordination as “the deliberate organisation of patient 
care activities between two or more participants (includ-
ing the patient) involved in a patient’s care to facilitate 
the appropriate delivery of health care services” [15, p.18]. 
However, many terms and definitions have been used to 
refer to care coordination, including ‘care management’, 
‘integrated care’, and ‘collaboration’ [15]. 
Identifying key coordination components can help sup-
port development of care coordination programs and 
evaluation of whether these components are delivered in 
practice as planned [16]. This may contribute towards a 
better understanding of whether and how these programs 
are effective. The clear identification of components may 
also help to standardise the delivery of such programs 
(where appropriate) to avoid variation in effectiveness 
due to differing implementation across settings [17]. It 
may also help to have an understanding of which com-
ponents are applicable across chronic conditions and 
which are most relevant for rare conditions. The detailed 
identification of components could inform evaluations 
of the potential costs of implementing care coordination 
for rare conditions within the healthcare system. Earlier 
reviews have identified and grouped components for 
long-term conditions. For example: McDonald et al. [15] 
grouped components into: essential care tasks, associated 
coordination activities and common features of interven-
tions to support coordination. Whereas, Davies et al. [18] 
identified nine coordination strategies: communication 
between service providers, use of systems to support care 
coordination, coordinating clinical activities, support for 
providers, support for patients, relationships between 
service providers, joint planning, funding/management, 
agreement between organisations and organisation of 
healthcare systems. One challenge associated with iden-
tifying coordination components is that it is difficult to 
distinguish between processes of care and coordination 
components, as care coordination may be interlinked with 
quality, delivery and organisation of care. [19].
There has been an international policy impetus to 
improve coordination for patients with rare conditions 
[7, 11]. A review of 11 national policies for rare diseases 
showed that initiatives to improve coordination vary 
across countries [11]. For example, the introduction of 
centres of expertise, networks, databases and registries 
[11]. 
No reviews have focused on care coordination for rare 
conditions. Whilst there have been reviews of care coor-
dination for chronic conditions conducted previously 
[15, 18], there is a need to update reviews to include new 
evidence. This review will update knowledge of care coor-
dination for common and rare chronic conditions. Given 
the paucity of reviews on rare conditions [20], this review 
will extend previous research by supplementing review 
findings with stakeholder consultations with patients, 
carers and healthcare providers who have experience 
of rare conditions. This will help to determine whether 
definitions and components of coordination are shared 
across all common and rare chronic conditions or whether 
some are specific to rare conditions. This will further our 
understanding of care coordination for rare conditions; 
given the lack of evidence that currently exists on care 
coordination for rare diseases. 
This review of reviews seeks to extend previous knowl-
edge by providing one of the first reviews of care coordi-
nation for rare conditions. To do this our review seeks to: 
(i) develop an updated definition of coordination of care 
for chronic conditions (rare and common), (ii) identify key 
components of care coordination for chronic conditions 
(rare and common), and categorise these according to 
their role in care coordination, and (iii) identify whether 
findings apply to rare conditions. 
The overarching aim of this study was to provide a defi-
nition of coordinated care and identify components of 
coordinated care for rare diseases. To do this, we draw on 
literature from chronic conditions. 
Methods
A scoping review methodology was used. This manuscript 
followed reporting standards outlined in the ‘Preferred 
Reporting Items for Systematic reviews and Meta-Analyses 
(PRISMA) extension for Scoping Reviews (PRISMA-ScR)’ 
checklist [21]. 
We followed six recommended steps for conducting 
scoping reviews [21]. We 1) defined the research ques-
tions, 2) identified relevant studies, 3) selected reviews, 
4) charted the data, 5) collated, summarised and reported 
the results and 6) consulted with stakeholders [22–24] 
(see Table 1). 
As scoping reviews need to be rigorous and transparent, 
we followed a systematic approach [22]. Scoping review 
methodology was appropriate as defining coordinated 
care and identifying components of coordinated care 
for common and rare chronic conditions is a broad topic 
which requires accumulation of evidence using different 
study designs [22]. Additionally, scoping review methodol-
ogy enabled a configurative approach (understanding and 
interpreting) which was appropriate for the purpose of 
the review [25, 26]. 
An optional step of consulting with stakeholders 
through focus group methodology was included as there 
is a need to explore stakeholder views on whether findings 
from a scoping review on both common and rare chronic 
conditions also can be applied to rare conditions. This is 
consistent with research which suggests that stakeholder 
contributions enhances the usefulness of review findings 
(Oliver, 2001; as cited in 22].
1) Defined research questions
The research team developed three research questions 
(see Table 1). 
2) Identified relevant studies
To identify relevant reviews, we searched electronic data-
bases, hand-searched key journals and reference lists of 
included reviews, and asked experts to identify missing 
papers. See Table 1 for eligibility criteria, information 
sources and development of search terms. 
Our search strategy included key words referring to 
coordinated care (including other terms for coordination, 
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e.g. integration), components of coordinated care, the 
target population (including rare and chronic condi-
tions), healthcare delivery and review methodology (See 
Supplementary file 1). 
3) Selected reviews
Duplicate records were removed prior to screening. To 
facilitate screening, guidelines were developed around 
the eligibility criteria. Articles were reviewed against 
inclusion and exclusion criteria in three stages: (i) titles, 
(ii) abstracts, and (iii) full texts. All titles, abstracts and full 
texts were screened by one researcher (1st author) and a 
percentage of records were screened by an independent 
researcher (2nd author/TS) [22]. Researchers met to discuss 
decisions, resolve discrepancies and amend guidelines 
(see Table 1). 
4) Charted the data 
A data extraction form was developed and used by one 
researcher (1st author) to chart the data for all included 
reviews (see Table 1). To ensure consistency and thor-
oughness, a second researcher extracted data from 10% 
of the reviews (2nd author). The researchers met to discuss 
and disagreements were resolved [22]. Data-extraction 
forms were also checked for comprehensiveness prior to 
publication. 
Information on definitions and components were 
extracted from the whole review paper. To include as 
many components as possible, we extracted all compo-
nents reported in review papers (including those reported 
from individual studies within the review). 
5) Collated, summarised and reported results 
Narrative analysis was used [35]. For each research 
question, findings were summarised using thematic 
analysis. 
To develop a definition of coordinated care, individual 
definitions were coded inductively. These codes were 
grouped by one researcher (1st author). Groups of codes 
were used to develop a preliminary definition (1st author). 
The definition was reviewed and amended by the wider 
research team. Stakeholder consultation findings were 
then used to adapt this definition. 
Components were coded and grouped by one researcher 
(1st author). Examples of groups included: ‘Planning’, 
‘Methods of coordination’, ‘Approaches of coordination’. 
A second researcher (3rd author) double-coded 10% of 
components (excluding those identified through the 
expert search) into these groups. Disagreements were 
discussed and resolved by the two researchers. One 
researcher (1st author) coded all remaining components 
according to rules agreed during this discussion. Groups 
of components were developed into themes and sub-
themes. The number of reviews that reported each theme, 
sub-theme, and component was recorded. This helped to 
identify which components were more commonly used 
for chronic diseases. 
To further develop our understanding of coordi-
nated care, individual components were reviewed and 
categorised (by 1st author) into four types of compo-
nents using component descriptions from review 
papers. The four types of components (see Figure 1) 
were developed in discussions between the first and 
last author, and reviewed by the whole team. The wider 
research team reviewed and agreed the categorisation 
of components. 
6) Consultation with stakeholders
Three focus groups (face-to-face or virtual) were con-
ducted with patients/carers (aged 18+) affected by rare 
conditions and healthcare professionals who support 
patients with rare conditions (aged 18+). Stakeholder 
Figure 1: Categorisation of components of coordinated care.
Components in the paent’s care 
pathway that may need to be 
delivered and coordinated 
(‘what’).  
 
These components may or may not be 
coordinated in pracce (e.g. paents and 
families could receive support but this 
may be uncoordinated) 
 
 
 
Components that tell us how to 
coordinate care (‘how’). 
 
 
These components provide ways in 
which care can be coordinated (e.g. 
having a care coordinator) 
 
Mul-purpose 
components 
 
These components 
outline how care 
could be coordinated 
and what components 
could be coordinated 
in a care pathway 
(e.g. planning)  
 
Components that contextualise care delivery and coordinaon. 
These components do not necessarily provide clear tangible methods for care 
coordinaon, but may be influence coordinaon (e.g. access to treatment) 
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consultations concentrated on rare conditions in order 
to explore whether the individual definitions and compo-
nents identified from the scoping review (which mainly 
covered common conditions) were applicable to rare con-
ditions (see Table 1). 
Participants were recruited through social media and 
charity partner organisations. To ensure a wide range of 
perspectives and experiences, we sampled participants 
using pre-specified eligibility criteria, including experi-
ence of care coordination, type of condition, age range 
and location). 
Focus group participants were sent a summary of 
preliminary scoping review findings prior to the focus 
group, which included examples of individual definitions 
from review papers and examples of components. This 
summary was reviewed by a Public Patient Involvement 
expert for clarity, accessibility, and appropriate level of 
information.
Participants gave informed consent for participation. 
A structured topic guide was used to facilitate conversa-
tions (Supplementary file 2). This covered participants’ 
condition or role at work; their thoughts on definitions 
of coordinated care; their views on the scoping review 
findings (including the definitions and components); rel-
evance to coordinated care for rare conditions; whether 
there were any components not identified and what com-
ponents worked well and were difficult.
Focus groups were audio-recorded and transcribed by 
a professional transcription company. Transcripts were 
checked for accuracy and fully anonymised. Two research-
ers (1st/4th authors) inductively coded the three focus 
group transcripts. Thematic analysis was used to analyse 
the data in relation to the three research questions [36]. 
Findings were discussed with the wider research team and 
refined.
Results
Review characteristics
One hundred and fifty-four reviews were included (for a 
list of reviews and their characteristics, see Supplemen-
tary files 3 and 4). Figure 2 outlines the review selection 
process.
Figure 2: A flow chart showing the study selection process (based on Moher et al [52]; PRISMA).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching 
(n= 2373) 
Hand search 
 
(n= 21) 
 
Records after duplicates (n=617) 
removed 
(n= 1777) 
Titles screened 
(n= 1777) 
Abstracts screened 
(n=750 ) 
Full texts assessed for eligibility 
(n= 518) 
Studies included in analysis 
(n= 154) 
Records excluded 
(n= 1027) 
Records excluded 
(n= 272) 
Records excluded 
(n= 364) 
  Expert search 
(n = 5 new 
records) 
  Reference lists 
of included 
reviews (n= 35 
new records) 
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The majority of reviews (n = 139) concerned care of 
common chronic conditions such as depression, anxi-
ety, diabetes and heart failure. Three reviews concerned 
care for a single rare condition [37–39] and 12 included 
both rare and common chronic conditions [40–51]. Rare 
conditions included: Anorectal malformations, Guillain-
Barré syndrome, Mayer-Rokitansky-Küster-Hauser syn-
drome, Sickle Cell disease, Juvenile Idiopathic Arthritis, 
Cystic Fibrosis, Spina bifida, Creutzfeldt-Jakob disease and 
Duchenne Muscular Dystrophy. 
Stakeholder consultation characteristics
Participant characteristics are shown in Table 2. 
1. What does coordinated care mean in the context 
of rare conditions?
The scoping review identified many terms and definitions 
used to describe coordinated care. The most frequently 
used terms included: integrated care models/integrated 
care (n = 34, 22.1%), transition/care transition (n = 18, 
11.7%), collaborative care (n = 15, 9.7%), transition from 
child to adult services (n = 15, 9.7%), disease management 
(n = 14, 9.1%), care coordination (n = 9, 9.5%) and case 
management/patient navigator (n = 8, 5.2%). See Supple-
mentary file 5 for terms, number of reviews and example 
definitions.
Stakeholder consultation participants reported that 
these terms and definitions were relevant for rare condi-
tions, emphasising the importance of communication, 
expertise and multidisciplinary teams for coordination. 
Healthcare professionals proposed that definitions need 
not specify a number of healthcare professionals and 
that transition is a component, but not a definition of 
coordination. In addition, stakeholder consultation find-
ings highlighted the importance of care coordination 
being delivered equitably across geographical areas, 
individualisation, the importance of the whole family, 
and the need to coordinate care across a patient’s whole 
lifetime (including antenatal care through to bereave-
ment care). 
A definition of coordinated care for rare conditions was 
developed (see Box 1). 
Table 2: Stakeholder consultation participant characteristics.
Focus group Total
1 2 3
Mode of delivery Virtual Face-to-face Face-to-face
Number of participants 7 4 6 17
Type of participant
Patients 4 N/A 2 6
Parents/carers1 3 N/A 4 7
Healthcare professionals2 N/A 4 N/A 4
Gender 
Male 1 0 3 4
Female 6 4 3 13
Age
29-59 6 N/A 3 9
60+ 1 N/A 2 3
Not specified 0 N/A 1 1
Diagnosis
One specific rare condition 4 N/A 3 7
Multiple chronic conditions (including 
at least one rare condition)
2 N/A 3 5
Undiagnosed 1 N/A 0 1
Number of regions3 represented 4 3 4 7
Note: 1 Parents and carers were included to capture views of caring for adults (n = 2) and children (n = 4) with rare, ultra-rare or 
undiagnosed conditions.
2 Job roles included consultants, nurses and a representative from a rare disease organisation (who had previous experience as a 
healthcare professional). In addition to their clinical role, one healthcare professional also worked for a rare disease organisation.
3 Regions refers to regions within the United Kingdom, including regions within England, in addition to Scotland, Wales and North-
ern Ireland. 
N/A = not applicable as patients/carers and healthcare professionals were asked different eligibility questions.
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2. Components of coordinated care for rare conditions 
Scoping review components were grouped into five 
themes, each with a number of sub-themes. Themes 
were: 1) Care pathway (components that related to the 
care pathway), 2) Approaches (components relating to 
care/coordination approaches), 3) Support (compo-
nents relating to support), 4) Features (components 
relating to features of care), and 5) wider environment. 
Each theme had a number of sub-themes which each 
contained multiple components (see Supplementary 
file 6 for themes, sub-themes, individual components, 
the number of reviews that they were reported in and 
the type of components). 
As the scoping review findings focus mainly on com-
mon chronic conditions, the stakeholder consultation 
findings were used to situate the relevance of compo-
nents identified from the scoping review in the context 
of rare diseases. The next section integrates both the 
scoping review findings and the stakeholder consulta-
tion findings in order to highlight aspects of stakeholder 
consultation findings that supported, refuted or extended 
scoping review findings. Illustrative quotes are shown in 
Supplementary file 7.
Many components were identified. Figure 3 provides 
an overview of scoping review and stakeholder consul-
tation findings. The figure provides a summary of com-
ponents within each of the four categories: components 
that may need to be coordinated inform how to coordi-
nate care, have multiple roles and contextualise coordi-
nation. Each category is discussed in more detail below. 
Potential interactions between types of components are 
also highlighted. For example, the factors which contextu-
alise coordination may influence which components may 
be needed to coordinate care. In turn, different types of 
‘how’ components may be needed to coordinate different 
types of components in a patients’ care pathway. 
‘What’ care pathway components
Components that may need to be coordinated are related 
to administration, assessment and diagnosis, planning, 
review and evaluation, feedback, follow-up care and 
technology. The scoping review found that components 
relating to these aspects of care were frequently reported. 
For example: development of care plans (61.7%), follow-
up care (52.6%), monitoring (51.3%), assessment of physi-
cal and mental health status (37.7%), reminders (26.6%), 
telecare (24%) and feedback for healthcare professionals 
(18.2%). Stakeholder consultation findings highlighted 
the importance of these components in the context of 
rare diseases. For example, assessment and diagnosis were 
identified as key elements for providing access to nec-
essary care. While identified as important, participants 
reported not having care plans or regular reviews despite 
their potential to prevent crises and ensure ongoing provi-
sion of appropriate care. 
The scoping review highlighted many support com-
ponents for patients, carers and families which need to 
be coordinated. For example: education/skills training 
for patients (73.4%), self-management support (54.6%), 
psychological support for patients (50%) and support 
for carers (26%). Stakeholder consultation findings indi-
cated that support for patients, carers and families with 
rare conditions was a crucial component of care includ-
ing support for a range of needs (medical, psychological, 
practical, emotional and social), and support from various 
people (healthcare providers, peers, schools, patient sup-
port groups). Despite the importance of support, patients 
reported a lack of support and information provision for 
rare and undiagnosed conditions.
Finally, scoping review findings highlighted support 
required by healthcare professionals in providing care 
for patients with chronic conditions. Key support compo-
nents included education (32.5%) and training (31.2%). 
Stakeholder consultation suggested that healthcare pro-
fessionals working with patients with rare conditions 
needed support in accessing specialist knowledge, and 
addressing perceived fears, anxieties and negative atti-
tudes towards treating rare conditions. However, those 
providers who had developed expertise were perceived to 
be equipped to provide quality care for people with rare 
conditions. This highlights the importance of training and 
education for care providers of people with rare condi-
tions; including providers within healthcare, educational 
and voluntary sectors. 
Box 1: Definition of coordinated care for rare conditions (additions from stakeholder consultation findings in bold).
Coordination of care involves working together across multiple components and processes of care to enable everyone 
involved in a patient’s care (including a team of healthcare professionals, the patient and/or carer and their family) to 
avoid duplication and achieve shared outcomes, throughout a person’s whole life, across all parts of the health and care 
system, including: 
•	 Care from different healthcare services (e.g. different medical disciplines - medical, mental health, behavioural, 
health promotion)
•	 Care from different healthcare settings (including primary and secondary; community settings e.g. social care) and 
locations (e.g. rural/urban)
•	 Care across multiple conditions, or single conditions that affect multiple parts of the body
•	 The movement from one service, or setting, to another
Coordination of care should be family-centred, holistic (including a patient’s medical, psychosocial, educational 
and vocational needs), evidence-based, with equal access to coordinated care irrespective of diagnosis, patient 
circumstances and geographical location.
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Components indicating ‘how’ care can be coordinated
Components outlining ‘how’ care can be coordinated are 
discussed below. There is potential overlap between some 
of these components and they are not mutually exclusive 
(e.g. ‘condition-specific’ centres or single visit approaches 
may use some of the other identified components in order 
to coordinate care).
Coordination through someone taking responsibility
Care could be coordinated using components relating 
to healthcare professionals, patients, and/or carers tak-
ing responsibility for coordinating care. Scoping review 
findings highlighted frequently reported components 
related to responsibility, including: coordination (e.g. 
collaboration, case management, disease management, 
an integrated approach) (70.8%) and responsibility for 
coordination by one healthcare provider (70.8%). Other 
components included patients’ coordinating their own 
treatments (16.9%). 
Stakeholder consultation findings provide support for, 
and extend review findings by suggesting that for rare 
conditions, having someone take responsibility for coor-
dinating care is key. However, as with scoping review find-
ings, ‘who’ should take responsibility was more contested. 
Options included: healthcare professionals, patients or 
carers, administrative coordinators, departmental advo-
cates, or GPs acting as gatekeepers for care for patients 
with rare conditions. Stakeholder consultation findings 
indicated that healthcare professionals as coordinators 
were perceived as helpful. Participants talked about a lack 
of formal care coordinator for many rare conditions and 
undiagnosed conditions. Similarly, patients and carers 
expressed concerns about whether individual coordinators 
could effectively coordinate everyone’s care due to limited 
capacity. The appropriateness of patients and/or carers as 
coordinators and what their role should be was unclear. 
Some patients/carers and healthcare professionals indi-
cated that patients may be best placed to coordinate care 
whereas others emphasised negative implications and 
views against coordinating their own care. Patients and 
carers mostly wanted to be seen as care partners, with 
control over some but not all aspects. An administra-
tive coordinator was also discussed as valuable and nec-
essary by healthcare professionals, patients and carers. 
Findings therefore indicate that there may not be a single 
best approach when considering responsibility. Instead, 
a model of responsible coordinator(s) that best suit the 
whole family’s needs and situation should be negotiated 
during conversations about such responsibilities. 
Coordination through specialist centres or joined up clinics
Care could be coordinated through specialist centres or 
joined up clinics. Scoping review findings indicated many 
different options for coordinating care through such cen-
tres, including: single visit approaches (40.3%), joint clin-
ics or consultations (14.9%) and specialist or condition 
specific clinics (22.7%). Stakeholder consultation findings 
highlight that for rare conditions, specialist/condition-
specific clinics were perceived as useful methods of coor-
dination and many patients and carers reported attending 
specialised services. But, they are not available for all rare 
or undiagnosed conditions. Participants mostly reviewed 
clinics positively but also expressed views on: wanting to 
go to a clinic for some things but not others and clinics 
not being delivered to a standard. Clinics were thought 
to improve communication, and reduce traveling. Barriers 
to coordinating care through specialist centres included: 
needing funding, needing a diagnosis, needing ways to 
assess whether the centre is in fact a centre of excellence, 
needing space and the move from specialist to general 
clinics. 
Coordination through communication 
Care could be coordinated through differing methods 
of communication by healthcare professionals, patients 
and carers, including verbal and written communication 
and the use of technology. Many components identified 
in the scoping review related to verbal and written com-
munication, including communication between provid-
ers and patients (57.1%), using and sharing documenta-
tion (46.8%), and team meetings to discuss coordination 
(76.6%). 
These findings were supported by stakeholder consul-
tation findings which indicated a lack of communication 
in practice for rare conditions. For example, findings indi-
cated that documentation is often not shared with rele-
vant care providers; resulting in a lack of care coordination 
for people with rare conditions. Patients reported acting 
as a medium for sharing documents between healthcare 
providers. This sometimes involved carrying large quanti-
ties of paperwork to appointments. Similarly, healthcare 
professionals were perceived by patients as not talking to 
each other; which resulted in message fatigue for patients 
and carers (repeating the same information multiple 
times). Using forms of identification for rare conditions 
(e.g. using Linnaean numbers, wearing pendants or using 
health passports) was perceived to be something that 
could facilitate coordination. 
“¶114: you know, you should have access and all 
those people should speak to each other because 
it’s an interconnected condition and they don’t, 
in fact it’s quite hard to find a single person who 
knows.” (FG-PC1, patient)
Many components identified in the scoping review related 
to technology, including: electronic medical records 
(22.1%), communication systems/teleconferencing 
(22.7%), reminders for healthcare professionals (20.1%) 
and reminders for patients (7.1%). Similarly, stakeholder 
consultation findings indicated that patients, carers and 
healthcare providers thought that technology was a use-
ful way of improving communication and therefore coor-
dination for rare conditions. Participants reported many 
benefits including: facilitating communication between 
patients and providers outside and within the trust, shar-
ing information and providing forms of patient identifi-
cation. The need for joined up systems was highlighted 
as key for coordination. However, the NHS having many 
different systems that are not connected was perceived to 
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limit coordination. Additional challenges included: data 
protection, people not having access to technology and 
financial constraints.
Coordination through support
The scoping review identified that care could be coor-
dinated through different types of support for patients, 
families and healthcare professionals. Scoping review 
findings indicated that support may be provided from var-
ious sources, including healthcare professionals (includ-
ing healthcare, social care and voluntary sector), family 
members and peers. Examples of components relating 
to support for patients which can be used to coordinate 
care, included: education and information/skills training 
(73.4%), general support for patients (68.2%), opportuni-
ties to familiarise with services (9.7%), and support for car-
ers (26%). Similarly, scoping review findings indicate that 
some types of support for healthcare professionals may 
strengthen healthcare professionals’ capability to coordi-
nate care, including training (31.2%), education (32.5%) 
and supervision (30.5%). 
Stakeholder consultation findings highlighted that 
patient organisations and rare disease charities were per-
ceived to be key in coordination, as they support patients 
and carers to develop expertise to take control over their 
condition. Providing patients, carers and healthcare pro-
fessionals with the opportunity to familiarise themselves 
with services and development of clear expectations 
around coordination and self-management support was 
thought to help develop patients and carers expertise to 
coordinate and self-manage their care. This may be impor-
tant given the potential role of patients and carers in care 
coordination (as highlighted previously). Opportunities 
included: involving patients in ward rounds and decision 
making. Stakeholder consultation findings also extend 
scoping review findings by highlighting the integral 
nature of support from schools for patients with rare con-
ditions. Additionally, some participants reported a lack 
of support in some situations including for undiagnosed 
conditions and within private organisations (e.g. hous-
ing associations). A few patients and carers reported that 
access to support (e.g. hospice care) and support groups 
was limited for some rare and undiagnosed conditions. 
Other coordination methods
Scoping review findings and stakeholder consultations 
indicated some other methods that can also be used 
to coordinate care, including multidisciplinary team 
approaches (76.6%), having the same individual care pro-
vider throughout (a key support of continuity of care) 
(14.9%), development of care plans (61.7%) and other 
planning components e.g. planning who is responsible for 
which aspects of care (11.7%), referrals (37%) and the use 
of registries (18.2%).
Stakeholder consultation indicated that continuity of 
healthcare providers was particularly important when 
multiple family members experienced the same symp-
toms, however findings indicated a lack of continuity in 
care for rare conditions. A lack of continuity was perceived 
as an advantage for patients with rare conditions by some 
healthcare professionals. For example, when transitioning 
from child to adult services and needing to take responsi-
bility for self-managing the condition. The change in pro-
viders and the ‘transition’ component was perceived to be 
important in helping patients with rare conditions learn 
to advocate for themselves. 
Stakeholder consultation participants reported a lack of 
care plans for rare conditions. Yet, stakeholder consulta-
tions indicated that care plans can be used to coordinate 
care in both every day and emergency situations. For exam-
ple, planning can also help to coordinate care by facilitat-
ing team approaches and ensuring that teams are working 
towards shared goals; thus facilitating coordination. 
Components that contextualise coordination 
Scoping review findings demonstrated that evidence-
based practice, individual differences and the wider 
healthcare environment may influence coordination. 
Components relating to these factors included: guideline-
based treatment (37%), evidence-based treatment pro-
tocols (35.1%), individualised care (33.1%) and having a 
supportive environment for coordination (e.g. distance 
from treatment facilities/access to care) (31.2%). Stake-
holder consultation findings indicated that to promote 
quality care and coordination, centralised and shared care 
pathways are needed. Yet findings indicated a lack of care 
pathways or defined standards for rare conditions or that 
treatments are not delivered consistently to standards 
(where standards are available). 
Similarly, stakeholder consultation findings provided 
support for the importance of the wider healthcare envi-
ronment by highlighting components relating to access 
to care that were relevant for rare conditions, including 
parents/patients fighting for access and barriers prevent-
ing access to records, results and medication. In terms of 
getting to healthcare appointments, participants reported 
having to travel to access care but that they were happy 
to do so if it meant they received expert care. One of the 
key issues preventing access to care in rare conditions was 
perceived to be limited availability of healthcare profes-
sionals with expertise in their condition. To take limited 
expertise in each condition into account, findings also 
indicated the need to succession plan by training more 
experts. 
3. Application of definitions and components of care 
coordination from common chronic conditions to rare 
conditions 
Overall, stakeholder consultation findings indicated that 
scoping review components were comprehensive and 
relevant for people with rare conditions. Participants 
expressed that rare conditions are mostly chronic condi-
tions. As rare conditions and patients can vary substan-
tially, participants felt that all components should be 
available even if they were not applicable to all patients’ 
individual situations. 
“¶503: But P3 why are we living in a world where 
we have to pick one or two or three of these? Why 
can’t it be all of them?” (FG-PC1, patient)
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Despite the perceived relevance of components, many 
participants described a lack of coordination for patients 
and families living with rare conditions. Participants 
described having to attend multiple appointments on 
different days, gaps and delays in sharing of documents 
and disagreements between healthcare professionals. 
Similarly, participants expressed concerns regarding coor-
dination in emergency situations and the importance of 
participants taking control themselves in order to miti-
gate worries. 
Coordinating care for rare and undiagnosed conditions 
may have further complexities that limit care and coor-
dination. For example, difficulties diagnosing rare con-
ditions. Diagnosis of rare conditions depends on factors 
such as a clinician’s knowledge and ability to recognise 
symptoms. Yet, developing condition-specific expertise for 
rare conditions is challenging given the small numbers of 
people diagnosed with each condition. 
Despite many similarities between common and rare 
chronic conditions, participants expressed views that 
some components were missing or that need to be empha-
sised for rare conditions. These included: having someone 
to take responsibility for coordination; genome-based 
medicine/genetic screening; social support needs; coun-
selling; and, antenatal and bereavement care. In addition, 
participants expressed views that more focus should be 
given to undiagnosed patients and families for many of 
the components. 
“¶667: […] the whole of the NHS is, well, as [Patient 
charity] knows is going towards genome based 
medicine, so I think you need to recognise that.“ 
(FG-PC2, carer)
Discussion
Key findings
Our definition indicated that coordinated care for peo-
ple affected by rare conditions requires working together 
across multiple components and processes of care to 
ensure that everyone involved achieves shared outcomes 
across a person’s whole life throughout different parts of 
the health and care system. Our definition highlights that 
for rare conditions, coordinated care should be family-
centred, evidence-based and equitable for all.
These review findings suggest that many of the key com-
ponents and issues for coordinated care apply to both rare 
and common chronic conditions. However, stakeholder 
consultation findings highlighted additional components 
and context-specific issues that are relevant in the context 
of rare conditions.
How findings relate to previous research and policy
Many terms and definitions were used to refer to care 
coordination, supporting previous research [15, 53]. Our 
findings extend this research by developing a definition 
of coordination for rare conditions. Our definition sup-
ports previous research and the government’s rare disease 
strategy which highlight that care needs to be coordinated 
across boundaries, involve family members, be equitable 
and individualised [4, 7]. 
A key challenge of coordination is that almost all aspects 
of care are relevant to coordination; making it difficult 
to distinguish between aspects of care and coordination 
components [19]. In this paper, we grouped components 
in relation to their roles, providing context for coordina-
tion components within the wider healthcare pathway 
and environment. We outlined four types of components, 
those that may need to be coordinated, inform how to 
coordinate care, have multiple roles, or that contextual-
ise coordination. These categories overlap with those out-
lined in previous research [15, 18], but provide clarity on 
ways in which different coordination components may be 
involved in complex care processes. 
We identified far more reviews for common conditions 
than rare conditions, highlighting that little is currently 
known about coordination for rare conditions. Our find-
ings extend previous research by highlighting similarities 
between definitions and components of coordination for 
both common and rare chronic conditions. Stakeholder 
consultation findings indicated that despite similarities in 
need, coordination for rare conditions may be less con-
sistent; as components may not be delivered frequently 
in practice. This extends findings which indicate a lack of 
support [8], a lack of coordination, communication and a 
‘postcode lottery’ approach to care [5] for people with rare 
conditions. Focus group findings indicated that many of 
the care components outlined in the review were not cur-
rently delivered effectively or consistently for people with 
rare conditions, let alone coordinated.
The difficulties associated with coordination for peo-
ple with rare conditions in contrast to common chronic 
diseases may be attributed to complexities associated 
with rare conditions. For example, many rare conditions 
affect multiple parts of the body and many affect children. 
Therefore, care may need to be life-long, coordinated 
through transition periods, across multiple sectors (includ-
ing schools) and must take family needs into account. In 
addition, diagnosis and expertise may be challenging due 
to fewer people living with each rare condition. This may 
mean that patients have to travel away from their area to 
access care. This may further complicate coordination. 
These complexities support research which suggests that 
more care coordination is needed in cases of greater sys-
tem fragmentation, clinical complexity, and decreased 
patient capacity [15]. To account for this, findings indicate 
that we need an individualised approach to coordination 
for rare conditions. Some people may like to be more 
involved in coordination whereas other patients may need 
more coordination components in place. Stakeholder con-
sultation findings proposed that components should be 
available to patients with rare and chronic conditions, and 
there could be a discussion between patients and health-
care professionals to determine appropriate needs for 
each individual. 
Findings highlighted the role of patients and carers. 
Patient/carer roles included but were not limited to: tak-
ing responsibility for coordination, informing and updat-
ing healthcare professionals and fighting for access to care. 
For rare conditions, patients have a key role and in some 
cases are perceived as, or are responsible for coordination; 
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supporting the burden of treatment theory [54]. Patients 
taking responsibility may be appropriate for some but not 
all patients and carers; particularly when conditions are 
complex, e.g. in the case of rare conditions. Methods of 
coordination which offer support to patients and carers 
(e.g. self-management support/opportunities to familiar-
ise with services) may play an important role in involving 
patients/carers in coordination.
Limitations
Given the paucity of literature on rare conditions, it was 
necessary to conduct a review for common and rare 
chronic conditions. Inclusive definitions were used for 
both coordination and chronic diseases. Despite our 
inclusive strategy, we are unlikely to have captured every 
relevant review. To identify as many studies as possible, 
we conducted a comprehensive search which included 
contacting experts and searching the reference lists of 
included reviews. Inclusive definitions for coordination 
and chronic diseases were used and reviews included 
research covering a range of countries. 
Individual studies may be included in more than one of 
our included reviews. We based our analysis on the word-
ing reported in the review papers, not individual studies. 
Therefore, we have not accounted for the possibility that 
authors may have reported components from individual 
studies in different ways. Components reported in pub-
lished descriptions of interventions do not necessarily 
equate to the delivery of all components, therefore this 
review is limited to the components reported in the reviews. 
The initial categorisation of components was based on 
researcher judgement. To limit individual subjectivity, the 
categorisation of components was reviewed and agreed 
within the wider research team. It is possible that other 
researchers may have categorised components differently.
This review focused on the identification of coordina-
tion components, rather than testing the effectiveness 
of coordination. Whilst we have outlined many different 
ways in which care can be coordinated; the effectiveness 
of combinations of, or individual components on relevant 
outcomes (such as reduced waiting times, better health-
care outcomes, better experience) is not known.
Implications
Our findings may provide support for various international 
policy initiatives [7, 9, 11]. For example, our findings sup-
port the UK Strategy for Rare Diseases, as many of the 
components reported as necessary for coordination (e.g. 
diagnosis, care pathways, genetic testing, communication, 
care plans and training for healthcare professionals) were 
identified in our review [7]. Yet, our findings also highlight 
the complexity of delivering coordinated care by outlin-
ing many different options for coordinating care within 
practice. In particular, our findings emphasised the need 
for someone to take responsibility for coordination, as out-
lined in the NHS long term plan [9]. Our findings show that 
there are many ways in which responsibility could be man-
aged. Whilst many different methods have been identified, 
some methods of coordination may be more complicated 
and multi-faceted than others. For example, condition-spe-
cific centres could facilitate other methods of coordination, 
such as communication and team meetings.
The components outlined in this review can be used to 
develop and evaluate existing and new models of coor-
dination for common and rare chronic conditions. The 
contextual factors identified may need to be considered 
when developing models of care coordination for differ-
ent groups. 
Future research
Evaluating the effectiveness of individual components 
was not within the scope of this review. The Coordinated 
Care of Rare Diseases project [55] aims to develop a tax-
onomy of coordinated care models for people with rare 
conditions. The taxonomy will build on these findings and 
enable researchers to test effectiveness and cost-effective-
ness of different coordination models. Different care coor-
dination approaches could also be evaluated in practice. 
Conclusions
Coordinated care requires working together across mul-
tiple components and processes of care to ensure every-
one involved achieves shared outcomes across a person’s 
whole life throughout different parts of the health and 
care system. There are many components that could 
be delivered and coordinated as part of a patients’ care 
pathway, many ways to coordinate care and many factors 
which contextualise care coordination. Review findings 
indicate that many of the key components for coordi-
nated care apply to rare and common chronic conditions. 
Stakeholder consultation findings highlighted additional 
components and context-specific issues that are relevant 
for rare conditions.
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